Biogen Pharmachem Peer Comparison

BSE: 531752

₹0.28

₹0.00 (0.00%)

As on 02-Sep-2026IST

Market cap

₹29 Cr

Revenue (TTM)

₹1 Cr

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
Market cap (₹ Cr)	29	8,164	1,414	806	479
Revenue (₹ Cr)	1	12	222	--	78
Net Profit (₹ Cr)	-0.17	-0.19	20.50	-0.18	18.00
Net Margin (%)	-11.39	-1.42	9.14	-133.09	23.18
RoE (%)	-0.17	-0.27	--	-0.30	10.88
Price to Earnings	--	--	69.01	--	26.63
Price-To-Book	0.26	58.41	5.38	6.81	2.69

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
Operating Revenue	1.02	11.77	221.56	0.00	77.59
Total Income	1.46	13.12	224.15	0.14	77.65
Total Expenditure	1.62	13.22	190.74	0.31	16.39
EBITDA	-0.60	-1.45	30.82	-0.31	61.19
Depreciation	0.00	0.00	0.34	0.00	1.86
EBIT	-0.60	-1.46	30.48	-0.31	59.33
Interest	0.00	0.00	2.44	0.00	34.96
Other Income	0.44	1.36	2.59	0.14	0.07
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-0.17	-0.10	30.63	-0.18	24.44
Provision for Tax	0.00	0.09	10.14	0.01	6.45
Profit after Tax	-0.17	-0.19	20.50	-0.18	18.00

Liabilities (₹ Cr)

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
Shareholder's Funds	99.09	72.13	219.06	118.47	172.70
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.10	0.00	0.35	0.00	11.05
Current Liabilities	0.21	2.65	129.34	0.06	333.14
Total Liabilities	92.02	18.64	172.55	2.00	349.40

Assets (₹ Cr)

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
Non-Current Assets	98.91	2.59	4.01	116.77	14.71
Current Assets	0.49	33.69	344.52	1.76	498.16
Total Assets	92.02	18.64	172.55	2.00	349.40
Total Debt*	0.00	0.00	6.57	0.24	198.85
Net Current Assets	0.27	31.04	215.18	1.69	165.03
Contingent Liabilities	--	--	9.27	--	0.99

Cashflow (₹ Cr)

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
Cash From Operating Activities	-1.08	-17.85	-17.31	-0.27	-49.36
Cash Flow from Investing Activities	-32.62	-0.01	-0.01	0.39	-5.13
Cash from Financing Activities	35.70	17.89	15.74	--	60.02
Net Cash Inflow / Outflow	2.00	0.03	-1.58	0.12	5.52

Ratios

Profitability Ratios

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
ROCE (%)	-0.36	4.42	33.76	21.71	12.13
ROE (%)	-0.17	-0.27	24.44	-0.30	10.88
ROA (%)	-0.17	-0.40	7.60	-0.30	4.16
EBIT Margin (%)	-59.06	-12.36	13.76	--	76.47
Net Margin (%)	-11.39	-1.42	9.14	-133.09	23.18
Cash Profit Margin (%)	--	0.00	0.00	--	0.00

Growth Ratios

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
Revenue Growth (%)	-64.73	-41.87	21.94	--	48.70
EBIT Growth (%)	-136.88	-450.60	24.29	-62.83	55.00
Net Profit Growth (%)	-113.69	-152.84	8.15	-148.40	46.09
EPS Growth (%)	-116.99	-100.84	1.03	-98.45	32.90
Book Value Growth (%)	-0.52	2,123.31	69.32	19.19	10.86

Valuation Ratios

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
Price / Earnings	-127.97	-956.53	58.12	3,165.57	26.98
Price / Book Value	0.26	59.60	5.24	6.99	2.72
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.33
EV/EBITDA	-45.55	-5,740.65	44.87	-2,661.05	10.99
Market Cap (₹ Cr)	--	0.00	286.48	--	330.04

Solvency Ratios

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	--	--	0.08	0.15	0.95
Current Ratio	2.28	12.70	2.66	27.89	1.50
Quick Ratio	2.28	7.72	2.63	27.89	1.50
Interest Coverage	--	163.44	13.56	4,277.00	1.70

Operating Efficiency Ratios

	Biogen Pharmachem	Mrugesh Trading	Sobhagya Mercant	Sanmitra Commerc	Mangal Credit
Debtors to sales (%)	0.00	67.26	66.09	--	0.29
Asset Turnover	0.01	0.25	0.82	0.00	0.18
Receivable days	--	123.91	146.61	--	0.00
Inventory Days	--	206.23	4.47	--	0.00
Payable days	--	0.74	289.53	--	--
Cash Conversion Cycle	--	329.39	-138.45	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly